AddLife Financial Statements From 2010 to 2025
| ALIF-B Stock | SEK 149.40 0.20 0.13% |
Check AddLife AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AddLife AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . AddLife financial statements analysis is a perfect complement when working with AddLife AB Valuation or Volatility modules.
AddLife |
AddLife AB Company Current Valuation Analysis
AddLife AB's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current AddLife AB Current Valuation | 30.79 B |
Most of AddLife AB's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AddLife AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, AddLife AB has a Current Valuation of 30.79 B. This is 114.34% higher than that of the Healthcare sector and 236.72% higher than that of the Medical Instruments & Supplies industry. The current valuation for all Sweden stocks is 85.19% lower than that of the firm.
AddLife AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AddLife AB's current stock value. Our valuation model uses many indicators to compare AddLife AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AddLife AB competition to find correlations between indicators driving AddLife AB's intrinsic value. More Info.AddLife AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.41 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for AddLife AB is roughly 2.44 . Comparative valuation analysis is a catch-all model that can be used if you cannot value AddLife AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AddLife AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About AddLife AB Financial Statements
AddLife AB stakeholders use historical fundamental indicators, such as AddLife AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although AddLife AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in AddLife AB's assets and liabilities are reflected in the revenues and expenses on AddLife AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AddLife AB. Please read more on our technical analysis and fundamental analysis pages.
AddLife AB , together with its subsidiaries, supplies equipment, instruments, and reagents to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries in Sweden, Finland, Denmark, Norway, and internationally. AddLife AB was founded in 1906 and is headquartered in Stockholm, Sweden. AddLife AB operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 908 people.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in AddLife Stock
AddLife AB financial ratios help investors to determine whether AddLife Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AddLife with respect to the benefits of owning AddLife AB security.